Sanctuary Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
VCM
VPM
Sanctuary Advisors's BIIB Position: Q1 2026 in Review
Sanctuary Advisors increased its Biogen (BIIB) stake by 8.6% in Q1 2026, buying an estimated $82K and bringing the position to 5,617 shares worth $1.03M. The position accounts for 0.01% of the portfolio, ranked #1319.
Sanctuary Advisors first reported a position in BIIB in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.25M in Q2 2024. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Sanctuary Advisors held 5,617 shares of Biogen worth $1.03M as of Q1 2026.
- Sanctuary Advisors bought 445 Biogen shares in Q1 2026, an estimated $82K.
- Biogen made up 0.01% of Sanctuary Advisors's portfolio in Q1 2026, its #1319 holding.
- Sanctuary Advisors first reported a position in Biogen in Q2 2024 and has held it in 8 quarters since.
- Sanctuary Advisors's Biogen position peaked at $1.25M in Q2 2024.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Sanctuary Advisors's 13F filing for Q1 2026, filed 5 May 2026.